Helmut Jeggle
Chairman chez BIONTECH SE
Fortune : 141 M $ au 31/03/2024
Profil
Helmut Jeggle est un homme d'affaires qui a été à la tête de 23 entreprises différentes. Actuellement, il occupe le poste de président du conseil de surveillance de BioNTech SE, de directeur général d'AT Newtec GmbH, de co-directeur de Jossa Arznei GmbH, de co-directeur de Santo Service GmbH, de directeur général d'Avitop GmbH, de co-directeur général de Neuraxpharm Holding GmbH, Directeur général et directeur financier de Nx Biotech GmbH, Directeur général de Horus Sentilo Projektentwicklungsgesellschaft mbH, Directeur général de Salvia GmbH, Co-directeur général de SWB Holding GmbH (Bayern), Co-directeur général de A&T Grundstck 1 GmbH, Co-gérant de A&T Grundstck 2 GmbH, Co-gérant de Palais Berlin 1 GmbH, Président du conseil de surveillance de AiCuris Anti-infective Cures GmbH, Co-gérant de Santo Holding (Deutschland) GmbH, Chief Operating Officer & Co-gérant de Athos Service GmbH, co-directeur général de Objektgesellschaft Berlin Passauer Strae 5-7 mbH, co-directeur général de Objektgesellschaft Mnchen Jahnstrae 41 und Klenzestrae, directeur général de Santo Venture Capital GmbH, directeur général et associé général de ATHOS KG et directeur général de ATS Beteiligungsverwaltung GmbH. Il est également co-directeur général d'AT Impf GmbH et directeur général d'Apceth Biopharma Manufacturing Co. Gmbh et siège au conseil d'administration de 6 autres sociétés. Dans le passé, Helmut Jeggle a occupé les postes de directeur général de Klinge Pharma GmbH (Bavière), de président du conseil d'administration de Sidroga AG, de directeur général d'apceth Biopharma GmbH, de responsable de la planification et de l'analyse des activités chez H e x a l AG et de responsable de la planification et de l'analyse des activités chez Sandoz International GmbH. Helmut Jeggle a obtenu un diplôme de premier cycle de l'université des sciences appliquées de Neu-Ulm et un MBA de l'institut de gestion et de technologie de Stuttgart GmbH.
Détentions connues dans des sociétés publiques
Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
---|---|---|---|---|
BIONTECH SE
0,63% | 31/12/2023 | 1 525 967 ( 0,63% ) | 141 M $ | 31/03/2024 |
Postes actifs de Helmut Jeggle
Sociétés | Poste | Début |
---|---|---|
BIONTECH SE | Chairman | 02/06/2008 |
4SC AG | Director/Board Member | 05/06/2008 |
TONIES SE | Director/Board Member | 27/11/2021 |
ATS Beteiligungsverwaltung GmbH
ATS Beteiligungsverwaltung GmbH Investment ManagersFinance ATS Beteiligungsverwaltung GmbH (ATS Beteiligungsverwaltung) is an independent German private equity firm which is headquartered in Munich and was founded in 2006 by Andreas and Thomas Strüngmann, offering their know-how and strategic support to selected biotech companies. | Private Equity Investor | 17/08/2018 |
Solaris Pharma Corp.
Solaris Pharma Corp. Pharmaceuticals: MajorHealth Technology Solaris Pharma Corp. engages in the development and commercialization of specialty pharmaceutical products. Its topical dosage forms that are developed at its facility include ointments, gels, creams, lotions, solutions, sprays, and foams. The company was founded by Lakshmi Raghavan in 2014 and is headquartered in Bridgewater, NJ. | Director/Board Member | - |
Objektgesellschaft Berlin Passauer Straße 5-7 mbH
Objektgesellschaft Berlin Passauer Straße 5-7 mbH Real Estate DevelopmentFinance Objektgesellschaft Berlin Passauer Straße 5-7 mbH is a private company based in Munich, Germany. Part of Münchener Rückversicherungs-Gesellschaft AG, Objektgesellschaft Berlin Passauer Straße 5-7 mbH rents, leases, and owns land, buildings, and apartments. The German company was founded in 1997 and the CEOs are Helmut Jeggle and Thomas Peter Maier. | Chief Executive Officer | 04/06/2019 |
A&T Grundstück 1 GmbH
A&T Grundstück 1 GmbH Real Estate DevelopmentFinance A & T Grundstück 1 GmbH is a private company based in Munich, Germany. The CEOs of the German company are Thomas Maier, Sebastian Breyer, Helmut Jeggle. The company engages in buying and selling of commercial premises & non-residential buildings. | Chief Executive Officer | - |
A&T Grundstück 2 GmbH
A&T Grundstück 2 GmbH Real Estate DevelopmentFinance A & T Grundstück 2 GmbH is a private company based in Munich, Germany. The CEOs of the German company are Sebastian Breyer, Helmut Jeggle, Thomas Peter Maier. The company buys and sells land, buildings, and apartments. | Chief Executive Officer | - |
Palais Berlin 1 GmbH
Palais Berlin 1 GmbH Real Estate DevelopmentFinance Palais Berlin 1 GmbH is a German company that specializes in the buying and selling of land, buildings, and flats. The private company is based in Munich, Germany. The CEOs of the company are Thomas Maier, Helmut Jeggle, Sebastian Breyer. | Chief Executive Officer | - |
░░░░░░░░░░░░░░░░░░ ░░░░░░░░ ░░░░░░░░░░░ ░░ ░░░ ░░░░░░░░░░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | - |
░░░ ░░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
░░░ ░ ░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | - |
Anciens postes connus de Helmut Jeggle
Sociétés | Poste | Fin |
---|---|---|
░░░░░ ░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
░░ ░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░░░░ ░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░ ░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Formation de Helmut Jeggle
Neu-Ulm University of Applied Sciences | Undergraduate Degree |
Stuttgart Institute of Management & Technology GmbH | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 3 |
---|---|
4SC AG | Health Technology |
BIONTECH SE | Health Technology |
TONIES SE | Consumer Durables |
Entreprise privées | 41 |
---|---|
Santo Holding (Deutschland) GmbH
Santo Holding (Deutschland) GmbH Financial ConglomeratesFinance Santo Holding (Deutschland) GmbH operates as an investment holding company with focus on drug discovery and development. The company is based in Holzkirchen, Germany. | Finance |
Hexal AG
Hexal AG Pharmaceuticals: MajorHealth Technology H e x a l AG develops, produces, markets and distributes modern generics and medicinal products. Its areas of emphasis are cardiovascular medicinal products, pain therapy medications and gastrointestinal products. The company was founded in April 1986 and is headquartered in Holzkirchen, Germany. | Health Technology |
Ganymed Pharmaceuticals AG
Ganymed Pharmaceuticals AG BiotechnologyHealth Technology Ganymed Pharmaceuticals AG develops antibodies for the treatment of solid cancers. It focuses on developing ideal monoclonal antibodies that include cancer-selective targets for maximal high-precision anticancer potency, as well as mitigates the threat of toxicity. The company was founded by Özlem Türeci, Dirk L. Sebastian, Christoph Huber and Ugur Sahin in 2001 and is headquartered in Mainz, Germany. | Health Technology |
Sandoz International GmbH
Sandoz International GmbH Pharmaceuticals: GenericHealth Technology Sandoz International GmbH develops and manufactures generic pharmaceuticals. It produces finished dosage forms of such off-patent drugs as diabetes treatment Glucophage, GERD drug Prilosec, and cholesterol. The company was founded in 1996 and is headquartered in Holzkirchen, Austria. | Health Technology |
Vanguard AG
Vanguard AG Miscellaneous Commercial ServicesCommercial Services Vanguard AG engages in the development, manufacture, and sale of medical devices and equipment used for cardiology and endoscopy. The company was founded by Bernard Frieling and Robert Schrödel in 1998 and is headquartered in Berlin, Germany. | Commercial Services |
ATS Beteiligungsverwaltung GmbH
ATS Beteiligungsverwaltung GmbH Investment ManagersFinance ATS Beteiligungsverwaltung GmbH (ATS Beteiligungsverwaltung) is an independent German private equity firm which is headquartered in Munich and was founded in 2006 by Andreas and Thomas Strüngmann, offering their know-how and strategic support to selected biotech companies. | Finance |
AFFiRiS AG
AFFiRiS AG Medical/Nursing ServicesHealth Services AFFiRiS AG develops and produces vaccines for therapeutic treatment of chronic diseases. It provides research services and develops vaccines based on peptide antigens applied in the fields of biochemistry, molecular and cell biology, immunology and veterinary medicine. AFFiRiS was founded by Walter Schmidt and Frank Mattner in November 2003 and is headquartered in Vienna, Austria. | Health Services |
APK AG
APK AG Wholesale DistributorsDistribution Services APK AG provides recovery services of raw materials such as fossil fuels like oil, coal, gas, and renewable resources like plants. It also provides grinding and screening processes for hard rocks. The company was founded by Wolfgang Lindner in 2008 and is headquartered in Merseburg, Germany. | Distribution Services |
Athos Service GmbH
Athos Service GmbH Financial ConglomeratesFinance Athos Service GmbH operates as an investment company which focuses on the pharmaceutical business. It offers personal investment trust management services. The firm also provides financial advisory services. The company is headquartered in Munich, Germany. | Finance |
AT Newtec GmbH
AT Newtec GmbH Financial ConglomeratesFinance AT Newtec GmbH provides investment and management services. The firm’s investment operations focus on businesses engaged in the biotechnology research and development sector. The company was founded by Andreas Strungmann and Thomas Strungmann is headquartered in Munich, Germany. | Finance |
AiCuris GmbH & Co. KG
AiCuris GmbH & Co. KG Miscellaneous Commercial ServicesCommercial Services AiCuris GmbH & Co. KG provides research and development services for antiviral and antibacterial agents. The firm develops drugs against viruses such as human cytomegalovirus, herpes simplex virus, hepatitis B virus and human immunodeficiency virus. The company was founded in March 2006 and is headquartered in Wuppertal, Germany. | Commercial Services |
Jossa Arznei GmbH
Jossa Arznei GmbH Pharmaceuticals: MajorHealth Technology Jossa Arznei GmbH engages in the manufacture and distribution of pharmaceutical products. It holds interest health care and medicine support services. The company was founded March 4, 1997 and is headquartered in Munich, Germany. | Health Technology |
Sidroga AG | |
Objektgesellschaft München Jahnstraße 41 und Klenzestraße
Objektgesellschaft München Jahnstraße 41 und Klenzestraße Real Estate DevelopmentFinance Part of Münchener Rückversicherungs-Gesellschaft AG, Objektgesellschaft München Jahnstraße 41 und Klenzestraße is a residential property rental and leasing private company based in Munich, Germany. The CEOs of the German company are Helmut Jeggle, Sebastian Breyer, Thomas Maier. The company rents and leases residential properties, buildings, and apartments. | Finance |
AT Impf GmbH
AT Impf GmbH Finance/Rental/LeasingFinance AT Impf GmbH offers purchasing services. It also provides sales and acquisition services. The company was founded on November 12, 2008 and is headquartered in Munich, Germany. | Finance |
CorTec GmbH
CorTec GmbH Medical SpecialtiesHealth Technology CorTec GmbH develops a neuro-technological platform for brain activity measurement and stimulation. The firm specializes in the designing a platform based on the CorTec Brain Interchange technology, with focus on opening up therapeutic and diagnostic possibilities. Its application areas encompass treatment, rehabilitation, and assistance technique. The firm also engages in research and development partnerships that deal with technology development programs and funding initiatives. The company was founded by Thomas Stieglitz, Wolfgang Meier, Christina Schwartz, Jorn Rickert, Markus Raab, Christian Henle, Martin Schuttler, and Jorg Fischer in September 2010 and is headquartered in Freiburg, Germany. | Health Technology |
Pharma Radebeul GmbH
Pharma Radebeul GmbH Finance/Rental/LeasingFinance Part of Jossa Arznei GmbH, Pharma Radebeul GmbH is a private company that specializes in rentals and leases of industrial machinery. The company is based in Radebeul, Germany. Michael Riemenschneider has been the CEO of the German company since 2020. | Finance |
Santo Service GmbH
Santo Service GmbH Real Estate DevelopmentFinance Santo Service GmbH offers construction and management services for real estate. It holds interest in advising and financial management services. The company was founded on September 19, 2007 and is headquartered in Munich, Germany. | Finance |
Santo Vermögensverwaltung GmbH
Santo Vermögensverwaltung GmbH Investment ManagersFinance Santo Vermögensverwaltung GmbH provides asset management services. The company is located in Germany. | Finance |
Avitop GmbH | |
Neuraxpharm Holding GmbH
Neuraxpharm Holding GmbH Investment ManagersFinance Neuraxpharm Holding GmbH engages in the acquisition and administration of investments. It also manages its own assets. The company was founded on March 2, 2009 and is headquartered in Holzkirchen, Germany. | Finance |
SiO2 Medical Products, Inc.
SiO2 Medical Products, Inc. Medical SpecialtiesHealth Technology SiO2 Medical Products, Inc. manufactures pharmaceutical products. It offers vials, syringes, cartridges, microplates, blood tubes, and bioscience consumables. The company was founded by Robert Abrams in November 2011 and is headquartered in Auburn, AL. | Health Technology |
Santo Venture Capital GmbH | Finance |
Minaris Regenerative Medicine GmbH
Minaris Regenerative Medicine GmbH BiotechnologyHealth Technology apceth Biopharma GmbH operates as a contract development & manufacturing organization. The firm specializes in cell-based and gene therapy products (Advanced Therapy Medicinal Products, ATMPs). Its GMP services include quality management, quality control, assay development, process development, cell banking & formulation and project management. The company was founded in 2007 and is headquartered in Munich, Germany. | Health Technology |
Nx Biotech GmbH | |
Horus Sentilo Projektentwicklungsgesellschaft mbH
Horus Sentilo Projektentwicklungsgesellschaft mbH Investment ManagersFinance Horus Sentilo Projektentwicklungsgesellschaft mbH provides investment management services. The private company is based in Munich, Germany. The CEOs of the German company are Ulrich O. Fischer, Torsten Bischoff, Jürgen Böckeler. | Finance |
Salvia GmbH
Salvia GmbH Investment ManagersFinance Salvia GmbH (Salvia) is a venture capital firm founded in 2014 by Helmut Jeggle. The firm is headquartered in Holzkirchen, Germany. | Finance |
Solaris Pharma Corp.
Solaris Pharma Corp. Pharmaceuticals: MajorHealth Technology Solaris Pharma Corp. engages in the development and commercialization of specialty pharmaceutical products. Its topical dosage forms that are developed at its facility include ointments, gels, creams, lotions, solutions, sprays, and foams. The company was founded by Lakshmi Raghavan in 2014 and is headquartered in Bridgewater, NJ. | Health Technology |
Dr. Ernst Strüngmann Foundation gGmbH
Dr. Ernst Strüngmann Foundation gGmbH Miscellaneous Commercial ServicesCommercial Services Dr. Ernst Strüngmann Foundation gGmbH is a biotechnology research and development company based in Munich, Germany. Dr. Ernst Strüngmann Foundation gGmbH engages in research and development on biotechnology. The German company was founded in 2007, and its CEOs are Andreas Strüngmann, Thomas Strüngmann, and Thomas Maier. | Commercial Services |
ATB GmbH
ATB GmbH Financial ConglomeratesFinance ATB GmbH is an investment holding German company founded in 2004. The private company is based in Gera, Germany. | Finance |
LBG 2 GmbH
LBG 2 GmbH Real Estate DevelopmentFinance LBG 2 GmbH provides residential real estate services. The private company is based in Munich, Germany. The CEOs of the German company are Helmut Jeggle, Thomas Maier. | Finance |
Apceth Biopharma Manufacturing Co. Gmbh
Apceth Biopharma Manufacturing Co. Gmbh Miscellaneous Commercial ServicesCommercial Services Apceth Biopharma Manufacturing Co. Gmbh is a German company that engages in research and development in natural sciences, engineering, agricultural sciences, and medicine. The private company is based in Munich, Germany. | Commercial Services |
Klinge Pharma GmbH (Bayern)
Klinge Pharma GmbH (Bayern) Pharmaceuticals: MajorHealth Technology Klinge Pharma GmbH is a pharmaceutical company based in Holzkirchen, Germany. Klinge Pharma's mission is to innovate and improve upon traditional pharmaceutical practices. The German company's description emphasizes their commitment to doing things better and their belief that innovation and tradition go hand in hand. The private company was founded in 1933 by A. Klinge and is currently led by CEOs Thomas Strüngmann, Fabian Strüngmann, and Ines Bohn. | Health Technology |
Aicuris Anti-Infective Cures AG
Aicuris Anti-Infective Cures AG Miscellaneous Commercial ServicesCommercial Services Part of Santo Holding (Deutschland) GmbH, Aicuris Anti-Infective Cures AG aims to discover, develop, and deliver innovative, anti-viral drugs to immunocompromised patients aiming to prevent severe condition and life-threatening diseases. The private company is based in Wuppertal, Germany. Aicuris has developed a commercial drug as well as pipeline of clinical-stage and pre-clinical anti-viral candidates. Its lead product Prevymis® (letermovir), a first-in-class non-nucleoside cytomegalovirus (CMV) inhibitor, was licensed to MSD and is commercialized for the prevention of human CMV infections in immunocompromised patients who underwent an allogeneic hematopoietic stem cell transplantation or kidney transplantation. Aicuris wholly owned product candidate, Pritelivir, targeting resistant herpes simplex virus (HSV) infections in immunocompromised patients, is in phase 3 clinical development. The German company was founded in 2006 by Helga Rübsamen-Schaeff. Larry G. Edwards has been the CEO of the company since 2023. | Commercial Services |
IQM Finland Oy
IQM Finland Oy Information Technology ServicesTechnology Services IQM Finland Oy operates as a quantum computing company. It engages in building hardware for quantum computers that focuses on superconducting technology. The company was founded by Juha Johannes Vartiainen, Kuan Yen Tan, Jan Goetz, and Mikko Pentti Matias M?tt?nen and is headquartered in Espoo, Finland. | Technology Services |
SWB Holding GmbH (Bayern)
SWB Holding GmbH (Bayern) Financial ConglomeratesFinance SWB Holding GmbH is a German Munich-based company that was founded in 2013. The private company provides investment services. Thomas Peter Maier has been the CEO of the company since 2018. | Finance |
A&T Grundstück 1 GmbH
A&T Grundstück 1 GmbH Real Estate DevelopmentFinance A & T Grundstück 1 GmbH is a private company based in Munich, Germany. The CEOs of the German company are Thomas Maier, Sebastian Breyer, Helmut Jeggle. The company engages in buying and selling of commercial premises & non-residential buildings. | Finance |
A&T Grundstück 2 GmbH
A&T Grundstück 2 GmbH Real Estate DevelopmentFinance A & T Grundstück 2 GmbH is a private company based in Munich, Germany. The CEOs of the German company are Sebastian Breyer, Helmut Jeggle, Thomas Peter Maier. The company buys and sells land, buildings, and apartments. | Finance |
Palais Berlin 1 GmbH
Palais Berlin 1 GmbH Real Estate DevelopmentFinance Palais Berlin 1 GmbH is a German company that specializes in the buying and selling of land, buildings, and flats. The private company is based in Munich, Germany. The CEOs of the company are Thomas Maier, Helmut Jeggle, Sebastian Breyer. | Finance |
ATHOS KG
ATHOS KG Financial ConglomeratesFinance ATHOS KG is an investment holding German company founded in 2019. The private company is based in Holzkirchen, Germany. | Finance |
Objektgesellschaft Berlin Passauer Straße 5-7 mbH
Objektgesellschaft Berlin Passauer Straße 5-7 mbH Real Estate DevelopmentFinance Objektgesellschaft Berlin Passauer Straße 5-7 mbH is a private company based in Munich, Germany. Part of Münchener Rückversicherungs-Gesellschaft AG, Objektgesellschaft Berlin Passauer Straße 5-7 mbH rents, leases, and owns land, buildings, and apartments. The German company was founded in 1997 and the CEOs are Helmut Jeggle and Thomas Peter Maier. | Finance |